Publication:


abstract

nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions being the most common cause of chronic liver disease in Western countries. The apolipoprotein E (ApoE) gene has three major isoforms encoded by the ε2, ε3, and ε4 alleles, with the ε4 allele associated with hypercholesterolemia and the ε2 allele with the opposite effect. The role of apoE genotypes on NAFLD has been previously investigated with conflicting results. Our hospital-based case-control study conducted in Italy aims to explore the effect of the apoE genotypes on NAFLD risk and their effect on the clinical features of NAFLD patients. 310 NAFLD cases and 422 controls were genotyped for apoE. Adjusted odds ratios (ORs) and 95% confidence intervals (CI) from logistic regression were used to explore the relationship between NAFLD and apoE genotypes, as well as their interaction with selected demographic and lifestyle factors. ApoE ε4 allele carriers showed a statistically significant two-fold reduction of NAFLD risk (OR = 0.51, 95% CI: 0.28-0.93) compared with ε3 homozygotes. A statistically significant lower HDL cholesterol level was observed for ApoE ε4 carriers if compared with ε3/ε3 genotype or ApoE ε2 carriers with a nearly linear decreasing trend from ApoE ε2 to ApoE ε4 carriers. Our study reports for the first time a protective effect of the ε4 allele towards NAFLD that might be attributable to its role in the regulation of hepatic triglycerides rich very low-density lipoproteins secretion.

Related Articles
Variation at APOE and STH loci and Alzheimer's disease.
Behav Brain Funct. 2006
Variation at APOE and STH loci and Alzheimer's disease.
Zuo L, van Dyck CH, Luo X, Kranzler HR, Yang BZ, Gelernter J. Behav Brain Funct. 2006 Apr 7; 2:13. Epub 2006 Apr 7.
Review Association of apolipoprotein E genotypes with lipid levels and coronary risk.
JAMA. 2007
Review Association of apolipoprotein E genotypes with lipid levels and coronary risk.
Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, et al. JAMA. 2007 Sep 19; 298(11):1300-11.
The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Clin Biochem. 2007
The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T. Clin Biochem. 2007 Oct; 40(15):1150-6. Epub 2007 Jul 6.
Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk.
Mol Carcinog. 2000
Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk.
Moysich KB, Freudenheim JL, Baker JA, Ambrosone CB, Bowman ED, Schisterman EF, Vena JE, Shields PG. Mol Carcinog. 2000 Jan; 27(1):2-9.
Review The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls.
Hypertens Res. 2009
Review The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls.
Niu W, Qi Y, Qian Y, Gao P, Zhu D. Hypertens Res. 2009 Dec; 32(12):1060-6. Epub 2009 Oct 9.